Dabigatran Etexilate 150 mg  ''''

Dabigatran Etexilate 150 mg 
DABIGATREX is classified as a direct oral anticoagulant (DOAC) or a novel oral anticoagulant (NOAC). It works by inhibiting the activity of thrombin, an enzyme that plays a key role in the formation of blood clots. By blocking thrombin, DABIGATREX reduces the blood's ability to clot, which helps prevent the formation of harmful blood clots.DABIGATREX  should not be discontinued abruptly, as sudden cessation can increase the risk of blood clots. Any changes to the medication regimen should be discussed with a healthcare provider.It may interact with other medications, so it's essential to inform your healthcare provider about all the drugs you are taking.Common side effects of DABIGATREX  may include gastrointestinal symptoms like upset stomach, nausea, and diarrhea. It can also cause bleeding, which can be serious. Signs of bleeding to watch for include unexpected or prolonged bleeding from cuts, nosebleeds, or gums, as well as dark or bloody urine or stools. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now: https://www.sterisonline.com/product/dabigatrex-150-133288